Similar Articles
241 Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma
242 Gut microbiota modulating therapy for diabetes mellitus should be individualized
243 Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
244 Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages
245 Computed tomography-based multi-organ radiomics nomogram model for predicting the risk of esophagogastric variceal bleeding in cirrhosis
246 Construction and validation of a pancreatic cancer prognostic model based on genes related to the hypoxic tumor microenvironment
247 Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
248 Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
249 Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus
250 Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA